🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,88 USD

Máx. histórico

61,25

1785 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-51,22%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-2,96%

Cierre anterior

30,79

Rango de hoy

29,85 – 31,44

Volumen hoy

52.805.827

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
42,69 (puede no estar actualizado)
Dividend yield
5,59% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 17 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,76%
Fecha de pago Importe por participación
03/08/2011 0,1898 USD
11/05/2011 0,1898 USD
02/02/2011 0,1898 USD
04/11/2010 0,1708 USD
04/08/2010 0,1708 USD
05/05/2010 0,1708 USD
03/02/2010 0,1708 USD
04/11/2009 0,1518 USD
05/08/2009 0,1518 USD
06/05/2009 0,1518 USD
04/02/2009 0,3036 USD
05/11/2008 0,3036 USD
06/08/2008 0,3036 USD
07/05/2008 0,3036 USD
06/02/2008 0,3036 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/10/2016 30,63 30,93 30,50 30,74 +0,37% 1,39% 18.026.246
25/10/2016 30,38 30,71 30,35 30,63 +0,47% 1,19% 20.380.249
24/10/2016 30,65 30,70 30,41 30,48 -0,16% 0,96% 20.644.066
21/10/2016 30,76 30,79 30,53 30,53 -1,11% 0,83% 19.852.090
20/10/2016 30,83 31,06 30,83 30,87 -0,18% 0,77% 20.334.190
19/10/2016 31,07 31,17 30,83 30,93 -0,28% 1,10% 17.247.445
18/10/2016 31,06 31,19 30,94 31,02 +0,58% 0,79% 15.624.074
17/10/2016 30,91 31,03 30,82 30,83 -0,49% 0,71% 17.837.369
14/10/2016 31,05 31,21 30,99 30,99 -0,31% 0,73% 16.410.042
13/10/2016 30,90 31,21 30,85 31,08 -0,94% 1,17% 25.488.144
12/10/2016 31,44 31,54 31,25 31,38 -0,18% 0,91% 15.956.295
11/10/2016 31,84 31,85 31,25 31,43 -1,43% 1,88% 18.268.033
10/10/2016 31,93 32,11 31,85 31,89 +0,15% 0,80% 17.268.420
07/10/2016 31,97 32,26 31,71 31,84 -0,27% 1,72% 15.619.964
06/10/2016 32,05 32,07 31,76 31,93 -0,74% 0,98% 16.809.824
05/10/2016 32,00 32,24 31,95 32,16 +0,53% 0,89% 14.698.346
04/10/2016 31,89 32,17 31,79 31,99 +0,12% 1,19% 22.029.759
03/10/2016 32,00 32,00 31,67 31,95 -0,56% 1,04% 18.862.384
30/09/2016 31,73 32,28 31,69 32,13 +1,65% 1,85% 30.138.076
29/09/2016 32,20 32,32 31,59 31,61 -1,97% 2,27% 26.396.376
28/09/2016 32,12 32,26 31,96 32,25 +0,47% 0,92% 15.080.421
27/09/2016 32,05 32,14 31,76 32,10 +0,56% 1,18% 16.453.572
26/09/2016 32,18 32,27 31,71 31,92 -1,81% 1,74% 31.119.982
23/09/2016 32,41 32,61 32,27 32,50 +0,32% 1,05% 13.635.703
22/09/2016 32,57 32,67 32,32 32,40 -0,38% 1,05% 17.641.220
21/09/2016 32,16 32,57 32,01 32,52 +1,39% 1,74% 16.397.500
20/09/2016 32,11 32,20 31,88 32,08 +0,48% 1,00% 14.875.313
19/09/2016 32,25 32,29 31,87 31,93 -0,85% 1,29% 18.489.584
16/09/2016 32,44 32,47 32,10 32,20 -0,59% 1,14% 26.998.737
15/09/2016 32,15 32,57 31,83 32,39 +0,59% 2,30% 21.890.104